M.D. Technical University of Munich, Germany 1995
Internal Medicine, University of Tuebingen 2001
Hematology/Oncology, University of Tuebingen, 2003
Fellow, Royal College of Physicians & Surgeons of Canada 2008
Clinical Professor, University of British Columbia
Medical Oncologist, BC Cancer Vancouver Center
Chair, Provincial GU Tumor Group
Chair, BC Cancer Vancouver GU Systemic Therapy Clinical Trials
Christian Kollmannsberger, MD, FRCPC, is staff medical oncologist at the British Columbia Cancer Agency (BCCA) Vancouver Cancer Centre and Clinical Professor at the University of British Columbia. He graduated from the Technical University in Munich, Germany and received his clinical training in Internal Medicine, Hematology and Medical Oncology, mainly at University of Tuebingen, Germany.
Dr. Kollmannsberger's research is concentrated on genitourinary malignancies with a special interest in testicular and renal cell cancer. His research is focused on the investigation of mechanisms of treatment resistance, the development of novel treatment options and biomarkers, including miRNA-371/375 and others for testicular cancer.
Nationally and internationally, he has contributed to numerous trials in the field of renal cell carcinoma and testicular cancer. He has repeatedly served as faculty and member of the education/scientific committee for the Annual meeting of the American Society of Clinical Oncology (ASCO), the ASCO Genitourinary Cancers Symposium, and the Annual Meeting of the European Society of Medical Oncology (ESMO).
Currently, Dr. Kollmannsberger serves as chair of the BC Cancer Provincial Genitourinary Tumor Group, chair for the Genitourinary Systemic Therapy Clinical Trials Unit at BC Cancer Vancouver Centre, chair for the Canadian Clinical Trials Group Testis Cancer Disease Oriented Group, and member of the Canadian Clinical Trials Group Kidney Cancer Disease Oriented Group.